Author headshot

Holli Loomans-Kropp, PhD, MPH

Loomans-Kropp is an assistant professor in the division of cancer prevention and control at The Ohio State University James Comprehensive Cancer Center.

Most recent by Holli Loomans-Kropp, PhD, MPH

SPONSORED CONTENT
March 22, 2024
4 min read
Save

Metformin may reduce risk for overall cancer, GI malignancies, meta-analysis shows

Metformin may reduce risk for overall cancer, GI malignancies, meta-analysis shows

The commonly used diabetes drug metformin may reduce risk for cancer, according to study results published in Journal of the National Cancer Institute.